The purpose of the Stem Cell Therapeutic and Research Reauthorization Act of 2026 is to extend and update the Stem Cell Therapeutic and Research Act of 2005. This law aims to support and enhance stem cell research and therapies, particularly those involving cord blood, which is a valuable resource for treating various medical conditions. Key provisions of the new law include increased funding for the C.W. Bill Young Cell Transplantation Program.